Building and sustaining collaborative platforms in genomics and biobanks for health innovation

Hermann Garden, Naomi Hawkins and David Winickoff
Additional contact information
Hermann Garden: OECD
Naomi Hawkins: University of Exeter
David Winickoff: OECD

No 102, OECD Science, Technology and Industry Policy Papers from OECD Publishing

Abstract: Genomic and biobank collaborative platforms hold significant promise for the development of new discoveries and therapies. This paper explores the complex technical, legal and business challenges arising from genomics and biobanks, and brings together ideas and best practices from major national and international platforms, and from a diverse range of experts. The global sharing of biological samples and genomic data has been critical for accelerating our understanding of the biology and spread of COVID-19, and for the development of vaccines and diagnostics. Although some of the policy challenges in the field are well known, they have been reconfigured by the digitalisation of health innovation combined with the increasing complexity and volume of data, the push for global collaboration, and the growing awareness of ethical, legal, and social implications.

Keywords: biobanks; collaborative platforms; genomics; governance; health; innovation policy; sustainability (search for similar items in EconPapers)
Date: 2021-03-01
New Economics Papers: this item is included in nep-hea and nep-ino
References: Add references at CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1787/11d960b7-en (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oec:stiaac:102-en

Access Statistics for this paper

More papers in OECD Science, Technology and Industry Policy Papers from OECD Publishing Contact information at EDIRC.
Bibliographic data for series maintained by ().